MENLO PARK, Calif., Jan.

Researchers have published the largest single patient population study to date on a method for following patients with retrievable inferior vena cava (IVC) filters—devices used to keep blood clots from traveling to the lungs.

Journal of Vascular and Interventional Radiology Includes Largest Single Patient Population Study to Date on Placement Success, Patient Follow-up FAIRFAX, Va., Nov.

MENLO PARK, Calif., Sept.

Cancer patients with blood clots -- which occur in one of every 200 cancer patients and are the second most common cause of death among cancer patients -- gain no benefit from the insertion of an inferior vena cava filter (IVCF) to the anticoagulant medication fondaparinux (Arixtra).